InsuLife
PrivateLast Round
Debt
Apr 24, 2024
Est. Valuation
$26.13M
Total Funding Raised
$3.28M
Company Overview
InsuLife is a drug discovery company developing a transdermal, needle-free insulin and GLP-1 delivery technology designed for the administration of insulin without injections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B2C
Customer Profile
Revenue Share, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InsuLife Comparables
Compare InsuLife with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biotts | 74% | |
| Oramed Pharmaceuticals Inc. | 74% | |
| NuGen Medical Devices Inc. | 72% | |
InsuLife Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 24, 2024 | ||||
| Early Funding | Apr 24, 2024 | ||||
| Debt | Aug 22, 2023 | ||||
| Crowdfunding | Oct 13, 2022 | ||||
| Accelerator | Aug 25, 2020 | ||||
Grant | Jun 21, 2020 |
Key People
Founding team and executive leadership
InsuLife Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aleap | Accelerator |
| Innovasjon Norge | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors increased 303% MoM, reaching 1.4K.
- Feb 20, 2025
Monthly visitors increased 57% MoM.
InsuLife Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about InsuLife's valuation, stock price, and market status.